SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the successful completion of its second Phase II clinical trial, ...

From advanced nickel alloys to subsea monitoring systems, this article examines how materials science, surface engineering, ...

The search for effective and accessible therapies for diabetes continues to draw attention to medicinal plants with a long ...

Researchers have developed a 3D-printable concrete that reduces cement use by 40% using cellulose nanofibers and limestone ...

Microsoft has released a new research report warning that no single technology can reliably distinguish AI-generated content from authentic media, and that deepening reliance on any one method risks ...

Advancements in peptide and oligonucleotide synthesis via precision chemistry are transforming therapeutic development by ...

The World Health Organization (WHO) today announced that Libya has eliminated trachoma as a public health problem, a landmark victory for public health in WHO's Eastern Mediterranean Region. This hard ...

NOHM invites EoI for development of AI-enabled tools for early detection of emerging pathogens: Shardul Nautiyal, Mumbai Friday, February 20, 2026, 08:00 Hrs [IST] The National On ...

The exercised warrants were issued in connection with the Company's February 2024 financing and carried an exercise price of $0.20 per common share. The Company further announces that the remaining $0 ...

A new steering-based control method enhances autonomous robot tracking accuracy in open environments, crucial for safety in chemical processing facilities.

The integration of deep reinforcement learning with PD control in humanoid robots enhances gait stability and patient comfort during lower limb rehabilitation.

Engineered M13 phage-based biosensor offers rapid, label-free detection of SARS-CoV-2 spike protein, demonstrating femtogram-level sensitivity in tests.